New Cousteau-Linked...
Bio-Reference Labs Inc. (BRLI: NASDAQ)
$19.26 0.88 | 4.79%
06/04/12 - 04:00 PM ET
Company Income Statement
| Oct 2011 | Oct 2010 | Oct 2009 | Oct 2008 | |
| Sales | 558.64M | 458.02M | 362.65M | 301.07M |
| Cost of Sales | 276.82M | 223.60M | 176.28M | 147.87M |
| Gross Operating Profit | 281.82M | 234.42M | 186.37M | 153.20M |
| Selling, General, and Administrative Expenses | 207.05M | 174.23M | 138.28M | 116.26M |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income before D & A (EBITDA) | 74.78M | 60.20M | 48.09M | 36.94M |
| Depreciation & Amortization | 15.00M | 11.82M | 9.77M | 8.39M |
| Interest Income | 163.00K | 151.00K | 179.00K | 269.00K |
| Other Income - Net | 6.66M | 0.00 | 1.60M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 66.59M | 48.53M | 40.10M | 28.83M |
| Interest Expense | 1.75M | 1.57M | 1.51M | 2.14M |
| Pre-Tax Income | 64.85M | 46.96M | 38.59M | 26.69M |
| Income Taxes | 28.49M | 20.58M | 16.74M | 11.07M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 36.36M | 26.38M | 21.85M | 15.62M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 36.36M | 26.38M | 21.85M | 15.62M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 36.36M | 26.38M | 21.85M | 15.62M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
36.36M | 26.38M | 21.85M | 15.62M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 36.36M | 26.38M | 21.85M | 15.62M |
| Basic EPS from Continuing Ops. | 1.30 | 0.95 | 0.79 | 0.57 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 1.30 | 0.95 | 0.79 | 0.57 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 1.30 | 0.95 | 0.79 | 0.57 |
| Basic Normalized Net Income/Share | 1.30 | 0.95 | 0.79 | 0.57 |
| EPS fr Continuing Ops. | 1.29 | 0.94 | 0.79 | 0.56 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 1.29 | 0.94 | 0.79 | 0.56 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 1.29 | 0.94 | 0.79 | 0.56 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
1.29 | 0.94 | 0.79 | 0.56 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with BRLI
- Portfolio NameUser Type
- Contributor10 Small-Cap Stocks Poised ...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorSmall-Caps With Big Potential
- UserSPECULATIVE
- ContributorEarnings Short Squeeze Play...
- ContributorThree Growth Stocks for a B...
- UserRFW2
- ContributorTop 5 Small-Cap Stocks: Aug...
Latest BRLI Headlines from TheStreet
- Jarden, Bio-Reference Labs: Time to Buy? 03.15.12 | 03:03 pm
- Time To Jump Into Jarden, Bio-Reference Labs
03.15.12 | 05:03 am - 10 Small-Cap Stocks Poised to Rise, History Shows (Update1) 03.13.12 | 10:03 am
- Bio-Reference Labs Inc. Stock Upgraded (BRLI) 02.01.12 | 06:02 am
- Bio-Reference Labs Inc. Stock Downgraded (BRLI) 11.28.11 | 05:11 am
- Bio-Reference Rises On Unusually High Volume (BRLI) 11.08.11 | 01:11 pm
- Bio-References Not Done Growing, Says CEO
09.09.11 | 05:09 am - 5 Earnings Short-Squeeze Plays 08.23.11 | 01:08 pm
- Bio-Reference Reaches New 52-Week High (BRLI) 05.26.11 | 10:05 am
- Heavily Shorted Stocks That Could Pop on Earnings 05.24.11 | 07:05 am
Press Releases for BRLI
- BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter Fiscal Year 2012 - Business Wire 05.31.12 | 08:05 am
- Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings And Cash Flow From Operations - Business Wire 03.01.12 | 08:03 am
- Bio-Reference Laboratories, Inc. Announces Earnings Date For First Quarter Fiscal Year 2012 - Business Wire 02.23.12 | 08:02 am
- BioReference Announces 2012 Annual Meeting Date - Business Wire 02.08.12 | 03:02 pm
- BioReference To Launch Groundbreaking Solid Tumor Genotyping Test Through Its GenPath Oncology Laboratory - Business Wire 01.26.12 | 08:01 am
- BioReference Laboratories, Inc. Announces Contract With Corizon, Inc. To Provide Correctional Healthcare Laboratory Services - Business Wire 01.12.12 | 08:01 am
- Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings And Cash Flow For Fourth Quarter And Full Fiscal Year - Business Wire 12.08.11 | 08:12 am
- BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2011 - Business Wire 12.07.11 | 02:12 pm
- BioReference Laboratories, Inc. To Speak At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.07.11 | 08:12 am
- Bio-Reference Laboratories, Inc. And McKesson Specialty Health’s Onmark GPO Execute Purchasing Agreement - Business Wire 11.22.11 | 02:11 pm
Partner Headlines for BRLI
- Bio Reference Labs, Quest Diagnostics Inc., Laboratory Corp. Of America: Diagnosis Profits - Seeking Alpha 03.05.12 | 08:03 am
- 10 Highly Shorted, Rallying Stocks With Strong Sources Of Profitability - Seeking Alpha 02.02.12 | 08:02 am
- Bio-Reference: Loads Of Dirty Laundry - Seeking Alpha 11.13.11 | 09:11 am
- Jefferies Places Bio-References Labs Under Review - Benzinga 11.11.11 | 09:11 am
- UPDATE: StreetSweeper Posts Negative Article on Bio-Reference - Benzinga 11.10.11 | 01:11 pm
- Questions Raised Over Bio-Reference Labs - Benzinga 11.01.11 | 01:11 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Upgrades, Downgrades, Initiations and Other Changes for Friday - Seeking Alpha 05.27.11 | 04:05 pm
- 10 Health Care Companies You Can Be Proud to Own - Benzinga 04.08.11 | 06:04 pm
- Benzinga’s Volume Movers (MNTA, HAIN, BRLI, PAAS) - Benzinga 08.26.10 | 01:08 pm





